Adam Ang
Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.
PredicTx expands clinical trial from Australia to India and the Middle East while working towards TGA approval and CE marking.
Founded by a former financial analyst, Sol aims to close research and care gaps for Asian women navigating menopause and midlife.
Care GP CEO Melvin Chen discusses how the company is rolling out its platform nationwide.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.
Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.
Also, a new AI-driven genomics platform developed in Queensland can identify cancer biomarkers and predict tumour responses to chemotherapy.
Also, health IT company UCrest from Malaysia has received its first patent for its AI-powered digital platform from Taiwan.
About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.